发明名称 5H-THIAZOLO/3,2-a/PYRIMIDINE DERIVATIVE, PROCESS OF ITS PREPARATION, INTERMEDIATE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
摘要 <p>The invention is concerned with compounds of the general formula <CHEM> wherein R<1> signifies hydrogen, lower alkyl, phenyl or benzyl, R<2> signifies lower alkyl, lower alkoxy, -O(CH2)nN(R<13>)(R<14>), -(CH2)nN(R<13>)(R<14>) or -N(R<15>)(CH2)nN(R<13>)(R<14>), R<3>-R<12> signify hydrogen, halogen, trifluoromethyl, lower alkyl, cycloalkyl, lower alkoxy, hydroxy, nitro, cyano, -N(R<13>)2, phenyl, phenyloxy, benzyl or benzyloxy, or R<6> and R<7> together signify a benzene ring, R<13>-R<15> signify hydrogen, lower alkyl or cycloalkyl and n signifies 1-5, as well as their pharmaceutically acceptable salts. These compounds are suitable for the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia caused by pregnancy, cardiac arrest, hypoglycaemia, Alzheimer's disease,Huntington's chorea, ALS, dementia caused by AIDS, eye injuries, retinopathy, cognitive disorders, idiopathic parkinsonism or parkinsonism caused by medicaments as well as conditions which lead to glutamate-deficiency functions, such as e.g. muscle spasms, convulsions, migraine, urinary incontinence, nicotine addiction, psychoses, opiate addiction, anxiety, vomiting, chronic pain, dyskinesia and depressions.</p>
申请公布号 CZ9802239(A3) 申请公布日期 1999.02.17
申请号 CZ19980002239 申请日期 1998.07.16
申请人 F. HOFFMANN-LA ROCHE AG 发明人 ADAM GEO;KOLCZEWSKI SABINE;MUTEL VINCENT;WICHMANN JURGEN;WOLTERING THOMAS JOHANNES
分类号 C07D239/22;A61K31/505;A61K31/519;A61P1/08;A61P9/00;A61P13/02;A61P15/00;A61P25/00;A61P25/04;A61P25/18;A61P25/20;A61P25/24;A61P25/26;A61P25/28;A61P25/30;A61P27/02;A61P43/00;C07D239/00;C07D239/40;C07D277/00;C07D513/04;(IPC1-7):C07D239/70;A61K31/495;C07D239/93 主分类号 C07D239/22
代理机构 代理人
主权项
地址